No Data
No Data
Minerva University Earns Title of Most Innovative University in the World for Third Straight Year
SAN FRANCISCO, June 10, 2024 /PRNewswire/ -- Minerva University, celebrated for its forward-thinking, immersive approach to higher education, has once again been recognized as the most innovative uni
Minerva Neurosciences Announces Board and Audit Committee Changes
Minerva Neurosciences Price Target Cut to $7.00/Share From $11.00 by HC Wainwright & Co.
Minerva Neurosciences Price Target Cut to $7.00/Share From $11.00 by HC Wainwright & Co.
Minerva Neurosciences Is Maintained at Neutral by HC Wainwright & Co.
Minerva Neurosciences Is Maintained at Neutral by HC Wainwright & Co.
HC Wainwright & Co. Maintains Neutral on Minerva Neurosciences, Lowers Price Target to $7
HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the price target from $11 to $7.
Minerva Neurosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 197.87% HC Wainwright & Co. $11 → $7 Maintains Neutral 02/27/2024 368.09% HC Wainwright & Co. →
No Data